Current Australian clinical practice in use of botulinum toxin-A to manage paediatric hypertonicity.
Stephen J O'FlahertyKirsty StewartPublished in: Journal of paediatrics and child health (2021)
Clinical practice in BoNT-A management of paediatric hypertonicity was largely consistent in regard to maximum doses of OnabotulinumtoxinA (Botox) used. Dose modification and time between injection courses varied according to individual clinical presentation. Procedural sedation was used extensively.